Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign
Open Access
Abstract
Malignant Hyperthermia Susceptibility (MHS) is most commonly caused by pathogenic variants in the RYR1 gene. The proliferation of RYR1 Variants of Uncertain Significance (VUS) on diagnostic genetic panels poses a significant clinical challenge, often leading to unnecessarily complex clinical concerns. We report the case of a 27-year-old African American female with a personal history of recurrent exertional rhabdomyolysis found to have a heterozygous RYR1 c.13230G>C p.(Glu4410Asp) variant. She later tested negative via the gold-standard Caffein–Halothane Contracture Test (CHCT). A negative CHCT test with an in silico Rare Exome Variant Ensemble Learner (REVEL) score of 0.171 meets the ClinGen MHS Variant Curation Expert Panel (VCEP) criteria for reclassification of the variant to Likely Benign. Additionally, the high allele frequency isolated within the African American (AA) population suggests a benign, ancestry-specific polymorphism maintained within the AA population rather than a pathogenic MHS mutation. Therefore, reclassifying the variant to Likely Benign prevents unnecessary muscle biopsies and alterations to perioperative anesthetic management and reduces the need for family cascade testing, and reduces use of potentially suboptimal alternative anesthetic protocols.Keywords
Funding Information
- U.S. Department of War (Ref. R.0036258.5.36)
This publication has 18 references indexed in Scilit:
- Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic TestingJAMA Network Open, 2023
- Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibilityGenetics in Medicine, 2021
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification frameworkGenetics in Medicine, 2018
- Malignant hyperthermia2018
- Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteriaGenetics in Medicine, 2017
- Assessing the pathogenicity of RYR1 variants in malignant hyperthermiaBritish Journal of Anaesthesia, 2017
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Functional analysis ofRYR1variants linked to malignant hyperthermiaTemperature, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015